Mobility Global Inc. Common Stock vs Twist Bioscience Corp — how do they compare? Mobility Global Inc. Common Stock trades at $18.07 (market cap $5.71B), while Twist Bioscience Corp trades at $133.8 (market cap $9.82B). The key difference: Twist Bioscience Corp is the larger of the two by market cap, and Mobility Global Inc. Common Stock pays a 1.35% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mobility Global Inc. Common Stock for 0 Days and Twist Bioscience Corp for 27 Days on average.
| MBGL | TWST | |
|---|---|---|
Market Cap | $5.71B | $9.82B |
Volume | 3,135,791 | 2,115,226 |
Sector | Technology | Health |
52-Week High | $22.26 | $205.00 |
52-Week Low | $17.15 | $25.45 |
Typical Hold Time | 0 Days | 27 Days |
Enterprise Value | $7.53B | $9.75B |
Dividend Yield | 1.35% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TWST trades at $151.33, down 0.35% today, near its consensus price target of $153.70. The stock shows a bullish technical signal despite recent earnings misses, with revenue growth improving from $204M in 2022 to $377M in 2025. However, profitability remains a challenge with a net income margin of -31.66% and negative cash flows. Recent news highlights its role in Eli Lilly's AI-driven drug discovery platform, fueling investor optimism in the healthtech sector.
The outlook balances strong revenue growth and AI partnerships against persistent losses and high valuation multiples. Investment appeal hinges on the company's ability to translate top-line expansion into profitability, with analyst consensus leaning bullish but execution risks remaining elevated for stockholders.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Mobility Global Inc. provides automotive data and analytics across the vehicle lifecycle, operating brands including CARFAX, automotiveMastermind, Polk Automotive Solutions, and Market Scan for automakers, dealers, and consumers.
Read more on MBGL →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →